Outsourcing Leaders Debate CDMO Network Strategies Amid Policy Changes
- Panelists from Biogen, Pfizer, Astellas, and ROIS discussed the complexities of optimizing manufacturing networks in response to shifting policies and tariffs.
- Biogen oversees a network of over 50 sites, while Pfizer manages more than 300 contract manufacturers, highlighting the scale of operations in the industry.
Operational Impact
Biogen's extensive network and Pfizer's large-scale contract manufacturing operations illustrate the strategic considerations for outsourcing in the current environment.
Source: PharmaSource RSS